These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 21999204)
1. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways. Chang MC; Chen CA; Chen PJ; Chiang YC; Chen YL; Mao TL; Lin HW; Lin Chiang WH; Cheng WF Biochem J; 2012 Mar; 442(2):293-302. PubMed ID: 21999204 [TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9. Cheung LW; Leung PC; Wong AS Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127 [TBL] [Abstract][Full Text] [Related]
3. Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway. Chang MC; Chen CA; Hsieh CY; Lee CN; Su YN; Hu YH; Cheng WF Biochem J; 2009 Dec; 424(3):449-58. PubMed ID: 19747165 [TBL] [Abstract][Full Text] [Related]
4. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells. Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016 [TBL] [Abstract][Full Text] [Related]
5. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells. Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957 [TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts. Park CH; Chung JH J Dermatol Sci; 2011 Nov; 64(2):134-41. PubMed ID: 21872446 [TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Kim M; Murakami A; Kawabata K; Ohigashi H Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507 [TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Ellerbroek SM; Halbleib JM; Benavidez M; Warmka JK; Wattenberg EV; Stack MS; Hudson LG Cancer Res; 2001 Mar; 61(5):1855-61. PubMed ID: 11280738 [TBL] [Abstract][Full Text] [Related]
9. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. Lai KC; Huang AC; Hsu SC; Kuo CL; Yang JS; Wu SH; Chung JG J Agric Food Chem; 2010 Mar; 58(5):2935-42. PubMed ID: 20136087 [TBL] [Abstract][Full Text] [Related]
10. Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways. Liu KC; Huang AC; Wu PP; Lin HY; Chueh FS; Yang JS; Lu CC; Chiang JH; Meng M; Chung JG Oncol Rep; 2011 Jul; 26(1):177-84. PubMed ID: 21503582 [TBL] [Abstract][Full Text] [Related]
11. In vitro enhancement effect of humic acid on the progression of lung cancer cells. Lee WJ; Lu FJ; Wang SF; Chen YR; Tseng TH Chem Biol Interact; 2009 Oct; 181(3):463-71. PubMed ID: 19686714 [TBL] [Abstract][Full Text] [Related]
12. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase. Collins CS; Hong J; Sapinoso L; Zhou Y; Liu Z; Micklash K; Schultz PG; Hampton GM Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3775-80. PubMed ID: 16537454 [TBL] [Abstract][Full Text] [Related]
13. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation. Han H; Du B; Pan X; Liu J; Zhao Q; Lian X; Qian M; Liu M Mol Cancer Res; 2010 Nov; 8(11):1477-88. PubMed ID: 21047770 [TBL] [Abstract][Full Text] [Related]
14. Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells. Lu DY; Leung YM; Cheung CW; Chen YR; Wong KL Biochem Pharmacol; 2010 Oct; 80(8):1201-9. PubMed ID: 20615395 [TBL] [Abstract][Full Text] [Related]
15. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin α(5)β(1)/α(v)β(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Jin YJ; Park I; Hong IK; Byun HJ; Choi J; Kim YM; Lee H Cell Signal; 2011 Jan; 23(1):125-34. PubMed ID: 20816750 [TBL] [Abstract][Full Text] [Related]
16. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer. Tan X; Egami H; Ishikawa S; Sugita H; Kamohara H; Nakagawa M; Nozawa F; Abe M; Ogawa M Int J Oncol; 2005 May; 26(5):1283-9. PubMed ID: 15809719 [TBL] [Abstract][Full Text] [Related]
17. Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells. Lin KL; Tsai PC; Hsieh CY; Chang LS; Lin SR Chem Biol Interact; 2011 Nov; 194(2-3):148-58. PubMed ID: 22033475 [TBL] [Abstract][Full Text] [Related]
18. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. Kajanne R; Miettinen P; Mehlem A; Leivonen SK; Birrer M; Foschi M; Kähäri VM; Leppä S J Cell Physiol; 2007 Aug; 212(2):489-97. PubMed ID: 17348021 [TBL] [Abstract][Full Text] [Related]
19. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression. Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392 [TBL] [Abstract][Full Text] [Related]
20. Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Weng CJ; Chau CF; Hsieh YS; Yang SF; Yen GC Carcinogenesis; 2008 Jan; 29(1):147-56. PubMed ID: 18024477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]